BETTER THERAPEUTICS (BTTX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 4 123 sessions, September 5, 2025 to September 8, 2026
- Largest daily move
- +100% close of September 18, 2025
- 1-year change
- +0% closing prices, September 5, 2025 to September 8, 2026
Company Description
BETTER THERAPEUTICS (OTC: BTTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $5.5K.
BTTX has gained 0.0% over the past year. The last closing price was $0.0001.
For FY2022, BETTER THERAPEUTICS reported net income of -$39.8M and diluted earnings per share of -$1.69.
This page collects what Stock Titan holds for BTTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BETTER THERAPEUTICS (BTTX) closed at $0.0001 on September 8, 2026. Over the past 12 months, the price has gained 0.0%.
BTTX Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BETTER THERAPEUTICS has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include partnership, fda approval. View all BTTX news →
SEC Filings
Financial Highlights
operating income reached -$38.3M, and net income was -$39.8M. Diluted earnings per share stood at -$1.69. The company generated -$28.9M in operating cash flow. With a current ratio of 1.37, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in BETTER THERAPEUTICS (BTTX) currently stands at 1.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BETTER THERAPEUTICS (BTTX) currently stands at 1.0 days, down 33.3% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 88.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 23.0 days.
BTTX Company Profile & Sector Positioning
BETTER THERAPEUTICS (BTTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BTTX often look at related companies in the same sector, including NOVACCESS GLOBAL INC (XSNX), STATERA BIOPHARMA INC (STAB), RENOVACARE INC (RCAR), COMERA LIFE SCIENCES HLDG (CMRA), and AMPIO PHARMS INC (AMPE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BTTX's relative position within its industry.